Afrocentric InvestmentJSE:ACT 52 Shareholder Yield % is 3.05% as of Dec. 2025, which is 38% below its 10-year median of 4.94. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 653 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 68.91% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Afrocentric Investment's Shareholder Yield % was 3.05%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Afrocentric Investment Shareholder Yield % Related Terms
Afrocentric Investment Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Shareholder Yield % Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Afrocentric Investment (JSE:ACT) has a Shareholder Yield % of 3.05% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Afrocentric Investment and its competitors. This is 38% below median its historical median of 4.94. According to the industry distribution chart, Afrocentric Investment ranks #203 out of 653 companies in the Healthcare Providers & Services industry, placing it in the top 31.1%.
Is Afrocentric Investment's Shareholder Yield % too high?
Afrocentric Investment's current Shareholder Yield % of 3.05% is 38% below median its 10-year median of 4.94. The Healthcare Providers & Services industry median Shareholder Yield % is 0.10. Afrocentric Investment's value of 3.05% is 2950% above this industry median. Based on the distribution chart, Afrocentric Investment ranks #203 out of 653 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Shareholder Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #203 out of 653 companies for Shareholder Yield %. This puts Afrocentric Investment in the upper half of its industry. The industry median Shareholder Yield % is 0.10. Afrocentric Investment's value of 3.05% is 2950% above this benchmark. While the company's 10-year median is 4.94 vs. the industry median of 0.10, Afrocentric Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.10, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Shareholder Yield % of 3.05% is 2950% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Shareholder Yield % is 3.05%, which is 38% below median its own 10-year median of 4.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Shareholder Yield % is 3.05%, which is 38% below median its 10-year median of 4.94 and 2950% above the Healthcare Providers & Services industry median of 0.10. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Shareholder Yield % is 3.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Shareholder Yield %: 3.05% (38% below median its 10-year median of 4.94)
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 2950% above the Healthcare Providers & Services median (#203 of 653)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
